Economic Performance

Elanco offers proven solutions to cattle producers looking to improve feed efficiency, increase gains and optimize endpoint management. 

CATTLE IMPLANT MYTH-BUSTING

Cattle implants are proven tools. See how Component with Tylan from Elanco busts cattle implant myths and maximizes your implant investment.

FOR ALL PRODUCTS: The label contains complete use information, including cautions and warnings. Always read, understand, and follow the label, and use directions.


Rumensin®:

CAUTION: Consumption by unapproved species or feeding undiluted may be toxic or fatal. Do not feed to veal calves.

DIRECTIONS FOR USE:

Growing beef steers and heifers fed in confinement for slaughter:

For improved feed efficiency: Feed 5 to 40 g/ton of monensin (90% DM basis) continuously in a complete feed to provide 50 to 480 mg/hd/day.

For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii: Feed 10 to 40 g/ton (90% DM basis) to provide 0.14 to 0.42 mg/lb. of body weight/d, depending upon severity of challenge, up to a maximum of 480 mg/hd/day.

Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) or in a dry lot, and replacement beef and dairy heifers:

For increased rate of weight gain: Feed 50 to 200 mg/hd/day in at least 1.0 lb. of Type C Medicated Feed. Or, after the fifth day, feed 400 mg/hd/day every other day in 2.0 lbs. of Type C Medicated Feed. The Type C Medicated Feed must contain 15 to 400 g/ton of monensin (90% DM basis). Do not self-feed.

For the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii: Feed at a rate to provide 0.14 to 0.42 mg/lb. of body weight/day, depending upon the severity of challenge, up to a maximum of 200 mg/hd/day. The Type C Medicated Feed must contain 15 to 400 g/ton of monensin (90% DM basis).

Type C free-choice medicated feeds: All Type C free-choice medicated feeds containing Rumensin must be manufactured according to an FDA-approved formula/specification. When using a formula/specification published in the Code of Federal Regulations (CFR), a Medicated Feed Mill license is not required. Use of Rumensin in a proprietary formula/specification not published in the CFR requires prior FDA approval and a Medicated Feed Mill License.


Optaflexx®:

CAUTION: Not for animals intended for breeding.

DIRECTIONS FOR USE:

Complete feed

For increased rate of weight gain and improved feed efficiency: Feed 8.2 to 24.6 g/ton of ractopamine hydrochloride (90% DM basis) continuously in a complete feed to provide 70 to 430 mg/hd/d for the last 28 to 42 days on feed.

For increased rate of weight gain, improved feed efficiency and increased carcass leanness: Feed 9.8 to 24.6 g/ton of ractopamine hydrochloride (90% DM basis) continuously in a complete feed to provide 90 to 430 mg/hd/d for the last 28 to 42 days on feed.

Top Dress

For increased rate of weight gain and improved feed efficiency: Feed 70 to 400 mg/hd/d of ractopamine hydrochloride (90% DM basis) continuously in a minimum of 1.0 lb./hd/d top dress Type C Medicated Feed (maximum 800 g/ton ractopamine hydrochloride) during the last 28 to 42 days on feed.

Carcass leanness effects are not an approved indication for use when feeding ractopamine by top dress feeding methods.


Component® with Tylan®:

DIRECTIONS FOR USE:

Administer one dose in the ear subcutaneously according to label directions.


Tylan®:

CAUTION: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

DIRECTIONS FOR USE:

For reduction of incidence of liver abscesses associated with Fusobacterium necrophorum, and Arcanobacterium pyogenes: Feed continuously at 8 to 10 g/ton of tylosin (90% DM basis) to provide 60 to 90 mg/hd/d.


HeifermaX®:

DIRECTIONS FOR USE:

HeifermaX 500: Heifers fed in confinement for slaughter
For increased rate of weight gain, improved feed efficiency and suppression of estrus (heat): Feed 0.5 to 2.0 lbs./hd/d in a Type C Medicated Feed to provide 0.25 to 0.5 mg/hd/d.

HeifermaX 500: Heifers intended for breeding
For suppression of estrus (heat): Thoroughly mix HeifermaX in the supplement to provide 0.5 mg/hd/d of melengestrol acetate.


Encore®:

DIRECTIONS FOR USE:

Administer one dose in the ear subcutaneously according to label directions.


Compudose®:

DIRECTIONS FOR USE:

Administer one dose in the ear subcutaneously according to label directions.